For cancer patients, oncologists often have the final word
“For terminally ill cancer patients, the final days of life are immensely personal, having the choice to continue cancer treatments, or to stop treatments and prioritize a more comfortable passing. What a patient wants, however, isn’t always what they receive, according to a Rutgers Health study published in the journal Cancer.”
Trastuzumab Rezetecan Is Safe, Efficacious for Patients With HER2-Mutated Non-Small Cell Lung Cancer
“Key Takeaways: Trastuzumab rezetecan achieved a 73% objective response rate in HER2-mutated NSCLC patients, surpassing trastuzumab deruxtecan in efficacy. The HORIZON-Lung trial involved 94 patients, assessing safety, tolerability, and efficacy of trastuzumab rezetecan in advanced NSCLC.”
OCFA firefighters among hundreds helping research health effects of Eaton and Palisades fires
“CYPRESS, Calif. (KABC) — A fire captain with the Orange County Fire Authority who survived cancer has teamed up with the University of Arizona and other partners to research the effects of exposure to carcinogens and other toxins to firefighters during the Eaton and Palisades fires.”
First Patient With Small Cell Lung Cancer Dosed With Peluntamig
“The multi-center, first-in-human, open-label, phase 2/3 SKYBRIDGE study is investigating the safety, tolerability, pharmacokinetics and initial efficacy of peluntamig in patients with advanced or refractory cancers expressing DLL3. Additionally, a phase 1 trial of peluntamig is being conducted in China. The study plans to enroll and estimated 203 patients as submitted in 2024.”
AI successfully reduces workload in lung cancer screening
“A study by researchers from the University of Liverpool and the Research Institute for Diagnostic Accuracy, Netherlands, has demonstrated that artificial intelligence (AI) can significantly improve the efficiency of lung cancer screening.”
Sweet potato extracts slow breast and lung cancer growth, study finds
“A study led by researchers from Tennessee State University, USA, has found that methanolic extracts of sweet potato leaves and stems can inhibit the growth of breast and lung cancer cells. The findings are published in the journal BMC Complementary Medicine and Therapies.”
Vaccines: the next frontier of lung cancer treatment and prevention
“Dr Keith Knutson, a Mayo Clinic Immunologist and Cancer Vaccine Researcher, talks to ITIJ about the potential for vaccines to help treat and prevent types of cancer”
Biond Biologics to Regain Full Rights to BND-22, a Novel Immune Checkpoint Inhibitor Targeting the ILT2 Receptor
“Following positive results from the Phase 1 dose escalation study, BND-22 (SAR444881) is now being tested in Phase 2 trials as monotherapy for patients with cholangiocarcinoma and in combination with cetuximab in patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC).”
NP leader scores $750,000 grant with hopes of boosting lung cancer screening uptake by the thousands
“A noted nurse practitioner and researcher has scored a $750,000 grant, which will help her team to potentially boost lung cancer screening uptake by the thousands. Lisa Carter-Bawa, PhD, MPH, is a behavioral scientist with nearly 20 years of clinical experience as an NP. She’s part of a group of experts at Hackensack Meridian Health in New Jersey, which has a plan to partner with community groups to improve awareness around low-dose CT.”
Lung Cancer Biomarker Testing & Screening Lag Behind
“While biomarker testing can help determine the choice of treatment, the report shows that insurance coverage for biomarker testing is only required in some states. Only 15 states require insurance coverage of comprehensive biomarker testing, five states require some plans to cover testing, and 30 states and Washington, DC, do not require any coverage of biomarker testing.”
LUPER Study Evaluates Lurbinectedin Plus Pembrolizumab in Relapsed SCLC
“Lurbinectedin plus pembrolizumab demonstrated “promising efficacy” in patients with relapsed small cell lung cancer (SCLC), according to results from the phase 1/2 LUPER study.”
Utahns face elevated risk of radon, non-smoking lung cancer. Here’s where that risk is higher.
“Kerri Robbins loves her home, so it was terrible to find out it made her sick. Robbins is one of thousands of Utahns who have developed lung cancer after radon exposure. Utah has the lowest rate of smoking in the nation, but lung cancer is the leading cause of cancer death in the state, according to the U.S. Environmental Protection Agency.”
